(Q67666804)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1696426%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

meta-analysis

0 references

title

A comparison of antiarrhythmic drugs for the suppression of ventricular ectopic depolarizations: a meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1696426%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

A comparison of antiarrhythmic drugs for the suppression of ventricular ectopic depolarizations: A meta-analysis (English)

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

1 November 2022

1 reference

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

1 November 2022

author name string

D. M. Salerno

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1696426

1 November 2022

K. J. Gillingham

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1696426

1 November 2022

D. A. Berry

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1696426

1 November 2022

M. Hodges

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1696426

1 November 2022

language of work or name

English

0 references

publication date

1 August 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1696426%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

16 September 2019

https://api.elsevier.com/content/article/PII:000287039090078C?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

https://api.elsevier.com/content/article/PII:000287039090078C?httpAccept=text/plain

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

1 November 2022

published in

American Heart Journal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1696426%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

volume

120

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1696426%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1696426%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

page(s)

340-353

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1696426%20AND%20SRC:MED&resulttype=core&format=json

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

16 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Ventricular Premature Beats and Mortality after Myocardial Infarction

1 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Ventricular ectopic beats and their relation to sudden and nonsudden cardiac death after myocardial infarction

1 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction

1 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Prevalence, characteristics and significance of ventricular tachycardia (three or more complexes) detected with ambulatory electrocardiographic recording in the late hospital phase of acute myocardial infarction

1 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Effect of antiarrhythmic drugs on mortality after myocardial infarction

1 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Secondary prevention after myocardial infarction: A review of long-term trials

1 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Ambulatory Holter electrocardiography: choice of technologies and clinical uses

1 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Classification of antiarrhythmic drugs

1 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Comparative mechanisms of action of antiarrhythmic drugs

1 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Kinetics of onset of rate-dependent effects of Class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea-pig ventricle, and provide a theoretical basis for their subclassification

1 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Antiarrhythmic drug classification: new science and practical applications

1 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

A Classification of Antiarrhythmic Actions Reassessed After a Decade of New Drugs

1 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Meta-analyses of randomized controlled trials.

1 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Meta-analysis in clinical research

1 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Meta-analysis. A quantitative approach to research integration

1 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Antiarrhythmic drug effect mimicked by spontaneous variability of ventricular ectopy

1 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopic frequency

1 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Antiarrhythmic efficacy of encainide and quinidine: validation of a model for drug assessment

1 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Comparative study of encainide and disopyramide in chronic ventricular arrhythmias: a double-blind placebo-controlled crossover study

1 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Flecainide versus quinidine for treatment of chronic ventricular arrhythmias. A multicenter clinical trial

1 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

A double-blind, crossover comparison of flecainide acetate and disopyramide phosphate in the treatment of ventricular premature complexes

1 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Comparative study of encainide and quinidine in the treatment of ventricular arrhythmias

1 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Efficacy of flecainide in the management of ventricular arrhythmias: comparative study with amiodarone

1 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Comparative antiarrhythmic efficacy of verapamil, 17-monochloracetylajmaline, mexiletine and amiodarone in patients with severe chagasic myocarditis: relation with the underlying arrhythmogenic mechanisms

1 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Comparison of propafenone and disopyramide for treatment of chronic ventricular arrhythmias: placebo-controlled, double-blind, randomized crossover study

1 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Comparative effect of disopyramide and ethmozine in suppressing complex ventricular arrhythmias by use of a double-blind, placebo-controlled, longitudinal crossover design

1 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Comparison of lorcainide and quinidine in the treatment of ventricular ectopy

1 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Efficacy of propafenone compared with quinidine in chronic ventricular arrhythmias

1 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Lorcainide. A comparative trial with quinidine gluconate in patients with previously untreated ventricular arrhythmias

1 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Effect of tocainide and quinidine on premature ventricular contractions

1 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Comparative efficacy and safety of oral tocainide and quinidine for benign and potentially lethal ventricular arrhythmias.

1 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Efficacy of mexiletine in chronic ventricular arrhythmias compared with quinidine: A single-blind, randomized trial

1 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Mexiletine and quinidine in ventricular ectopy

1 November 2022

37

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Antiarrhythmic drug effect assessed from ventricular arrhythmia reduction in the ambulatory electrocardiogram and treadmill test: comparison of propranolol, procainamide and quinidine

1 November 2022

39

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Combination of procainamide and quinidine for better tolerance and additive effects for ventricular arrhythmias

1 November 2022

40

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

The effectiveness of antiarrhythmic agents on early-cycle premature ventricular complexes

1 November 2022

41

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Comparison of acebutolol with propranolol, quinidine, and placebo: results of three multicenter arrhythmia trials

1 November 2022

42

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Comparison of acebutolol and propranolol for treatment of chronic ventricular arrhythmia: a placebo-controlled, double-blind, randomized crossover study

1 November 2022

43

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Comparison of acebutolol and propranolol therapy for ventricular arrhythmias

1 November 2022

44

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Variability of spontaneous and exercise-induced ventricular arrhythmias in the absence and presence of treatment with acebutolol or quinidine

1 November 2022

46

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Comparative efficacy of oral sotalol and procainamide in patients with chronic ventricular arrhythmias: a multicenter study

1 November 2022

47

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS

1 November 2022

48

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Block of sodium currents by antiarrhythmic agents: Analysis of the electrophysiologic effects of propafenone in heart muscle

1 November 2022

49

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Inhibiton of $$\dot V_{\max } $$ of the action potential by propafenone and its voltage-, time- and pH-dependence in mammalian ventricular myocardium

1 November 2022

50

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Electrophysiologic effects of propafenone on canine ischemic cardiac cells

1 November 2022

51

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

A controlled trial of propafenone for treatment of frequent and repetitive ventricular premature complexes

1 November 2022

52

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

The multiple modes of action of propafenone

1 November 2022

53

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Effects of procaine amide, quinidine and ethmozin on delayed afterdepolarizations

1 November 2022

54

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Sodium current in single internally perfused myocardial cells. Effects of ethmozine and lidocaine.

1 November 2022

55

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Membrane Action of Ethmozin on Normoxic and Hypoxic Canine Purkinje Fibers

1 November 2022

56

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Ethmozine suppression of single and repetitive ventricular premature depolarizations during therapy: Documentation of efficacy and long-term safety

1 November 2022

57

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Effect of moricizine hydrochloride in reducing chronic high-frequency ventricular arrhythmia: results of a prospective, controlled trial

1 November 2022

59

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs

1 November 2022

60

1 reference

https://api.crossref.org/works/10.1016/0002-8703(90)90078-C

1 November 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1696426%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

1 reference